By Stephen Lin, PhD., CIRM Senior Science Officer A diabetic child is checking her blood sugar level (self glycaemia). Type 1 diabetes affects millions of people. It is a disease where beta islet cells in the pancreas are targeted by the body’s own immune system, destroying the ability to produce insulin. Without insulin, the body … Continue reading Scientists develop immune evading pancreas organoids to treat type 1 diabetes
islet cell transplantation
Stem Cell Agency Board Approves New Clinical Trial for Type 1 Diabetes
Dr. Peter Stock at the capitol in Sacramento in May 2016. Photo courtesy of Steve German. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $11.08 Million to Dr. Peter Stock at the University of California San Francisco (UCSF) to conduct a clinical trial for treatment of Type 1 Diabetes (T1D). … Continue reading Stem Cell Agency Board Approves New Clinical Trial for Type 1 Diabetes
The Stem Cellar 